Abstract
A major feature of magnetic resonance imaging (MRI) is the great variation possible in the choice of suitable scanning sequences to obtain optimal image contrast and the desired tissue differentiation. As with any other procedure, the sensitivity and specificity of MRI and, hence, its accuracy can be enhanced through the use of contrast media (CM). Despite the use of appropriate imaging techniques, more exact conclusions about the tissue integrity, function and perfusion of certain organ systems can, in most cases, only be drawn with the help of CM. Their use can also simplify the examination procedure itself or obviate other diagnostic methods. Wide-spread clinical use had demonstrated definite advantages of contrast-enhanced MRI over the plain examination. At present, contrast media are used world-wide in more than 25% of all MR examinations, depending on the indication and clinical experience.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
References
Lauterbur PC, Mendonca-Dias MH, Rudin AM (1978) Augmentation of tissue water proton spin-lattice relaxation rates by in-vivo addition of paramagnetic ions. Front Med Biol Eng 1: 752–759
Mendonca-Dias MH, Gaggelli E, Lauterbur PC (1983) Paramagnetic Contrast Agents in Nuclear Magnetic Resonance Medical Imaging. Seminars in Nuclear Medicine 13: 364–376
Sage MR (1982) Blood-brain barrier: Phenomenon of increasing importance to the imaging clinican. AJR 138: 887–898
Weinmann H-J, Press W-R, Gries H (199o) Tolerance of extracellular contrast agents for MM. Invest Radiol 25: S 49 - S5o
Vogler H, Platzek J, Schuhmann-Giampieri G et al. (1995) Preclinical evaluation of gadobutrol: a new, neutral, extracellular contrast agent for MRI. Eur J Radiol 21: 1–10
Kashanian FK, Goldstein HA, Blumetti RF et al. (1990) Rapid bolus injection of gadopentate dimeglumine: Absence of side effects in normal volunteers. AJNR Am J Neuroradiol 11: 853–856
Kanal E, Applegate GR, Gillen CP (1990) Review of adverse reactions including anaphylaxisin 426o intravenous bolus injections (Abstract 434). Radiology 177 (suppl): 159
Weinmann H-J, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of gadoliniumDTPA complex: a potential NMR contrast agent. Am J Roentgenol 142 (3): 619–624
Schuhmann-Giampieri G, Krestin G (1991) Pharmacokinetics of Gd-DTPA in Patients with chronic renal failure. Invest Radiol 26 (n): 975–979
Weinmann H-J, Laniado M, Mützel W (1984) Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 16: 167–172
Le Mignon MM, Chambon C, Warrington S, Davies R, Bonnemain B (1990) GD-DOTA. Pharmacokinetics and tolerability after intravenous injection into healthy volunteers. Inves Radiol 25 (8): 933–937
Mc Lachlan SJ, Eaton S, De Simone DN (1992) Pharmacokinetic behavior of gadoteridol injection. Invest Radiol 27 (1): 12–15
Van Wagoner M, Worah D (1993) Gadodiamide injection. First human experience with the nonionic magnetic resonance imaging enhancement agent. Invest Radiol 28 (1): 44–48
Lackner K, Krahe T, Götz R, Haustein J (1990) The dialysability of Gd-DTPA. Bydder G et al., (eds) Contrast Media in MRI, Bussum: Medicom Europe:321–326
Niendorf HP, Alhassan A, Balzer T, Clauß W, Geens V (1998) Sicherheit and Risiken von GdDTPA:Klinische Erfahrungen nach über 20 Millionen Anwendungen. In: Magnevist-Eine Monographie, Hrsg. Felix R, Heshild A, Blackwell Wissenschaftsverlag, 3. Auflage, S 27–38
Niendorf HP, Brasch RC (1993) Gd-DTPA Tolerance and Clinical Safety. In: MM Contrast Enhancement in the CNS: A Case Study Approach, Hrsg. Brasch RC, Raven Press, Ltd., New York, S 18
Elster AD (1990) Cranial MR imaging with Gd-DTPA in neonates and young infants: preliminary experience. Radiology 176: 225–230
Hamm B, Wolf KJ, Felix R (1987) Conventional and rapid MR imaging of the liver with Gd-DTPA. Radiology 164: 313–320
Rofsky NM, Earls JP (1996) A contrast agent for abdominal MR imaging. Magn Reson Imaging Clin N Am 4 (1): 73–85
Gallez B, Bacic G, Swartz HM (1996) Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP. Magn Reson Med 1996 35 (0: 14–19
Hahn PF, Stark DD, Weissleder R et al. (1990) Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiol 174 (2): 361–366
Chachuat A, Bonnemain B (1995) European clinical experience with Endorem. A new contrast agent far liver MM in moo patients. Radiologe 35 (11 Suppl 2): 274–276
Reimer P, Rummeny EJ, Daldrup HE et al. (1995) Clinical results with Resovist: a phase 2 clinical trial. Radiology 195 (2): 489–496
Adam G, Mühler A, Spuntrup E et al. (1996) Differentiation of spontaneous canine breast tumors using dynamic MR imaging with 24-Gadolinium-DTPA-cascade-polymer, a new blood-pool contrast agent for MR angiography. Experimental study in rabits. Invest Radiol 31 (5): 267–274
Anzai Y, Prince MR, Chenevert TL et al. (1997) MR angiography with an ultrasmall super-paramagnetic iron oxide blood-pool agent. J Magn Reson Imaging 7 (1): 209–214
References
Gramiak R, Shaw PM (1968) Echocardiography of the aortic root. Invest Radiol 3: 356–366
Ophir J, Parker KJ (1989) Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 15: 319–333
Fritzsch T, Mützel W, Schartl M (1986) First experience with a standardized contrast medium for sonography. In: Otto RC, Higgins CB (eds) New Developments in Thieme, Stuttgart, pp 141–149
Degenhardt F, Jibril S, Eisenhauer B (1996) Hysterosalpingo contrast sonography ( HyCoSy) for determining tubal patency. Clin Radiol 51: 15–18
Barnhart J, Levene H, Villapando E et al. (1990) Characteristics of Albunex, air-filled albumin microspheres for echocardiography. Invest Radiol 25: 162–164
Dittrich HC, Bales GL, Kuvelas T (1995) Myocardial contrast echocardiography in experimental coronary artery occlusion with a new intravenously administered contrast agent. J Am Soc Echocardiogr 8: 465–474
Schwarz KQ, Becher H, Schimpfky C, Vorwerk D, Bogdahn U, Schlief R (1994) A study of the magnitude of Doppler enhancement with SH U 508 A in multiple vascular regions. Radiology 193(1):195–201
Nanda N, Schlief R (1993) Advances in echo imaging using contrast enhancement. Kluwer, Dordrecht
Schlief R (1991) Ultrasound contrast agents. Curr Op Rad 3: 198–207
Bauer A, Becker G, Krone A, Fröhlich T, Bogdahn U (1996) Transcranial duplex sonography using ultrasound contrast enhancers. Clin Rad 51: 19–23
Sitzer M, Fürst G, Siebler M (1994) Usefulness of an intravenous contrast medium in the characterization of high grade internal carotid stenosis with color Doppler assisted duplex imaging. Stroke 25: 385–389
Allen CM, Balen FG, Musouris C, McGregor G, Buckenham T, Lees WR, (1993) Renal artery stenosis: diagnosis using contrast enhanced doppler ultrasound. Clin Rad 48: 5
Langholz J, Wanke M, Petry J, Schuermann R, Schlief R, Heidrich H (1993) Indikationen zur Unterschenkelarteriendarstellung mit Kontrastmittel bei der farbkodierten Duplexsonographie. Ultraschall Klin Prax 8 (3): 196
Becker G, Bogdahn U, Gehlberg C, Fröhlich T, Hofmann E, Schlief MD (1995) Transcranial color-coded real-time sonography of intracranial veins. Normal values of blood flow velocities and findings in superior sagittal sinus thrombosis. J Neuroimaging, 5 (2): 87–94
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Niendorf, H.P., Wels, T., Geens, V., Bauer, A., Schlief, R. (1999). Contrast Media for Clinical Magnetic Resonance Imaging and Ultrasound. In: Dawson, P., Clauss, W. (eds) Contrast Media in Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59957-6_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-59957-6_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-64759-1
Online ISBN: 978-3-642-59957-6
eBook Packages: Springer Book Archive